Literature DB >> 12112390

Decorin transfection in human mesangial cells downregulates genes playing a role in the progression of fibrosis.

Antonia Costacurta1, Giovanna Priante, Angela D'Angelo, Luigi Chieco-Bianchi, Salvatore Cantaro.   

Abstract

The proteoglycan decorin inhibits TGF-beta; therefore, it could antagonize progression of fibrotic diseases associated with activation of TGF-beta(1). The effect of decorin transfection in human mesangial cells (HMCs) on the expression of genes related to kidney fibrosis was investigated. HMCs, isolated from glomeruli of healthy portions of human kidneys removed due to carcinoma, were histochemically typed. Decorin cDNA cloned in a eukaryotic expression vector was transfected into HMCs. Gene expression of fibrogenetic cytokines and fibrotic proteins TGF-beta(1), PDGF-beta, alpha(1) collagen type IV, alpha(1) collagen type I, fibronectin, and tenascin was analyzed, by reverse transcription polymerase chain reaction (RT-PCR), 24 hr after transfection. Immunoblotting analysis of protein extracts using anti-decorin IgG, revealed a positive signal of about 52 MDa, corresponding to the molecular weight of decorin, in cultures transfected with the decorin gene. Decorin mRNA increased about 12 times in cultures transfected with the construct pCR3.1-Deco. Cells with increased decorin synthesis showed a 61% decrease of TGF-beta(1) mRNA, a 71% reduction of alpha1 collagen type IV mRNA, and a 29% reduction of fibronectin mRNA. This study is the first to investigate decorin transfection into human mesangial cells, and supports the use of the decorin gene to control the progression of glomerular and interstitial fibrosis in kidney diseases. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112390      PMCID: PMC6807966          DOI: 10.1002/jcla.10038

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  30 in total

1.  Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture.

Authors:  V M Kähäri; H Larjava; J Uitto
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

2.  Influence of decorin on fibroblast adhesion to fibronectin.

Authors:  M Winnemöller; G Schmidt; H Kresse
Journal:  Eur J Cell Biol       Date:  1991-02       Impact factor: 4.492

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Transforming growth factor beta in tissue fibrosis.

Authors:  W A Border; N A Noble
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

5.  The decorin high glucose response element and mechanism of its activation in human mesangial cells.

Authors:  Nadia Abdel Wahab; Susan Parker; Jean-Daniel Sraer; Roger M Mason
Journal:  J Am Soc Nephrol       Date:  2000-09       Impact factor: 10.121

6.  Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.

Authors:  W A Border; N A Noble; T Yamamoto; J R Harper; Y u Yamaguchi; M D Pierschbacher; E Ruoslahti
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

7.  The human decorin gene: intron-exon organization, discovery of two alternatively spliced exons in the 5' untranslated region, and mapping of the gene to chromosome 12q23.

Authors:  K G Danielson; A Fazzio; I Cohen; L A Cannizzaro; I Eichstetter; R V Iozzo
Journal:  Genomics       Date:  1993-01       Impact factor: 5.736

8.  Human decorin gene: intron-exon junctions and chromosomal localization.

Authors:  U Vetter; W Vogel; W Just; M F Young; L W Fisher
Journal:  Genomics       Date:  1993-01       Impact factor: 5.736

9.  Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.

Authors:  H Fakhrai; O Dorigo; D L Shawler; H Lin; D Mercola; K L Black; I Royston; R E Sobol
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

10.  Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha.

Authors:  A Mauviel; M Santra; Y Q Chen; J Uitto; R V Iozzo
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

View more
  6 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity.

Authors:  Cecilia Vial; Jaime Gutiérrez; Cristian Santander; Daniel Cabrera; Enrique Brandan
Journal:  J Biol Chem       Date:  2011-03-23       Impact factor: 5.157

3.  Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids.

Authors:  William H Catherino; Phyllis C Leppert; Matthew H Stenmark; Mark Payson; Clariss Potlog-Nahari; Lynnette K Nieman; James H Segars
Journal:  Genes Chromosomes Cancer       Date:  2004-07       Impact factor: 5.006

4.  OTUB1 overexpression in mesangial cells is a novel regulator in the pathogenesis of glomerulonephritis through the decrease of DCN level.

Authors:  Yan Zhang; Ruimin Hu; Huijuan Wu; Weina Jiang; Yu Sun; Yan Wang; Yanan Song; Tong Jin; Hongxia Zhang; Xin Mao; Zhonghua Zhao; Zhigang Zhang
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

Review 5.  Small leucine rich proteoglycans in host immunity and renal diseases.

Authors:  Wei Zou; Junhui Wan; Min Li; Juanjuan Xing; Qi Chen; Zhi Zhang; Yi Gong
Journal:  J Cell Commun Signal       Date:  2018-10-25       Impact factor: 5.908

6.  NecroX-5 exerts anti-inflammatory and anti-fibrotic effects via modulation of the TNFα/Dcn/TGFβ1/Smad2 pathway in hypoxia/reoxygenation-treated rat hearts.

Authors:  Vu Thi Thu; Hyoung Kyu Kim; Le Thanh Long; To Thanh Thuy; Nguyen Quang Huy; Soon Ha Kim; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Korean J Physiol Pharmacol       Date:  2016-04-26       Impact factor: 2.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.